C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes

Epigenetics

Volumn 8, Issue 6, 2013, Pages

  Lu, Jing ^a   Wen, Mingxin ^a   Huang, Yurong ^b   He, Xiuquan ^a   Wang, Yunshan ^a   Wu, Qi ^a   Li, Zengchun ^c   Castellanos Martin, Andres ^d   Abad, Mar ^e   Cruz Hernandez, Juan J ^e   Rodriguez, Cesar A ^e   Perez Losada, Jesus ^d   Mao, Jian Hua ^b   Wei, Guangwei ^a,b  

^a Shandong University   (China)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c TONGJI UNIVERSITY   (China)

^d UNIVERSITY OF SALAMANCA   (Spain)

^e HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Breast cancer; C2ORF40; DNA methylation; Metastasis; Mitosis; Proliferation

Indexed keywords

CELL CYCLE PROTEIN; C2ORF40 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; BREAST CANCER; C2ORF40 GENE; CANCER PATIENT; CANCER PROGNOSIS; CELL CYCLE M PHASE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; DNA METHYLATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PATHOGENESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; WOUND HEALING; BREAST TUMOR; FEMALE; GENE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MITOSIS; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, CDC; GENES, TUMOR SUPPRESSOR; HUMANS; MITOSIS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROGNOSIS;

EID: 84891684450     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.24626     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90; PMID:21296855; http://dx.doi.org/10.3322/caac.20107.
2. Zhang B, Beeghly-Fadiel A, Long J, Zheng W. Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol 2011; 12:477-88; PMID:21514219; http://dx.doi.org/10.1016/S1470-2045(11)70076-6.
3. Su T, Liu H, Lu S. Cloning and identification of cDNA fragments related to human esophageal cancer. Zhonghua Zhong Liu Za Zhi 1998; 20:254-7; PMID:10920976.
4. Steck E, Breit S, Breusch SJ, Axt M, Richter W. Enhanced expression of the human chitinase 3-like 2 gene (YKL-39) but not chitinase 3-like 1 gene (YKL-40) in osteoarthritic cartilage. Biochem Biophys Res Commun 2002; 299:109-15; PMID:12435396; http://dx.doi.org/10.1016/S0006-291X(02)02585-8.
5. Mirabeau O, Perlas E, Severini C, Audero E, Gascuel O, Possenti R, et al. Identification of novel peptide hormones in the human proteome by hidden Markov model screening. Genome Res 2007; 17:320-7; PMID:17284679; http://dx.doi.org/10.1101/gr.5755407.
6. Yue CM, Deng DJ, Bi MX, Guo LP, Lu SH. Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma. World J Gastroenterol 2003; 9:1174-8; PMID:12800218.
7. Götze S, Feldhaus V, Traska T, Wolter M, Reifenberger G, Tannapfel A, et al. ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. BMC Cancer 2009; 9:447; PMID:20017917; http://dx.doi.org/10.1186/1471-2407-9-447.
8. Mori Y, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Kurehara H, et al. Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Oncol Rep 2007; 18:981-5; PMID:17786363.
9. Li LW, Yu XY, Yang Y, Zhang CP, Guo LP, Lu SH. Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo. Int J Cancer 2009; 125:1505-13; PMID:19521989; http://dx.doi.org/10.1002/ijc.24513.
10. Li W, Liu X, Zhang B, Qi D, Zhang L, Jin Y, et al. Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion. J Exp Clin Cancer Res 2010; 29:89; PMID:20598162; http://dx.doi.org/10.1186/1756-9966-29-89.
11. Li LW, Yang Y, Li XY, Guo LP, Zhou Y, Lu SX. Tumor-suppressing function of human esophageal cancer related gene 4 in esophageal squamous cell carcinoma. Zhonghua Yi Xue Za Zhi 2010; 90:2713-7; PMID:21162904.
12. Sabatier R, Finetti P, Adelaide J, Guille A, Borg JP, Chaffanet M, et al. Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer. PLoS One 2011; 6:e27656; PMID:22110708; http://dx.doi.org/10.1371/journal.pone.0027656.
13. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL, et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 2006; 10:529-41; PMID:17157792; http://dx.doi.org/10.1016/j.ccr.2006.10.009.
14. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006; 10:515-27; PMID:17157791; http://dx.doi.org/10.1016/j.ccr.2006.10.008.
15. Stingl J, Caldas C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 2007; 7:791-9; PMID:17851544; http://dx.doi.org/10.1038/nrc2212.
16. Vanaja DK, Ehrich M, Van den Boom D, Cheville JC, Karnes RJ, Tindall DJ, et al. Hypermethylation of genes for diagnosis and risk stratification of prostate cancer. Cancer Invest 2009; 27:549-60; PMID:19229700; http://dx.doi.org/10.1080/07357900802620794.
17. Esteller M. Dormant hypermethylated tumour suppressor genes: questions and answers. J Pathol 2005; 205:172-80; PMID:15643671; http://dx.doi.org/10.1002/path.1707.
18. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 2007; 16(Spec No 1):R50-9; PMID:17613547; http://dx.doi.org/10.1093/hmg/ddm018.
19. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007; 446:153-8; PMID:17344846; http://dx.doi.org/10.1038/nature05610.
20. Li LW, Li YY, Li XY, Zhang CP, Zhou Y, Lu SH. A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma. BMC Cancer 2011; 11:52; PMID:21288367; http://dx.doi.org/10.1186/1471-2407-11-52.
21. Reddy SK, Rape M, Margansky WA, Kirschner MW. Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation. Nature 2007; 446:921-5; PMID:17443186; http://dx.doi.org/10.1038/nature05734.
22. Williamson A, Wickliffe KE, Mellone BG, Song L, Karpen GH, Rape M. Identification of a physiological E2 module for the human anaphase-promoting complex. Proc Natl Acad Sci U S A 2009; 106:18213-8; PMID:19822757; http://dx.doi.org/10.1073/pnas.0907887106.
23. Wagner KW, Sapinoso LM, El-Rifai W, Frierson HF, Butz N, Mestan J, et al. Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin. Oncogene 2004; 23:6621-9; PMID:15208666; http://dx.doi.org/10.1038/sj.onc.1207861.
24. Ozawa A, Lick AN, Lindberg I. Processing of proaugurin is required to suppress proliferation of tumor cell lines. Mol Endocrinol 2011; 25:776-84; PMID:21436262; http://dx.doi.org/10.1210/me.2010-0389.
25. Mirabeau O, Perlas E, Severini C, Audero E, Gascuel O, Possenti R, et al. Identification of novel peptide hormones in the human proteome by hidden Markov model screening. Genome Res 2007; 17:320-7; PMID:17284679; http://dx.doi.org/10.1101/gr.5755407.
26. Dang X, Podvin S, Coimbra R, Eliceiri B, Baird A. Cell-specific processing and release of the hormone-like precursor and candidate tumor suppressor gene product, Ecrg4. Cell Tissue Res 2012; 348:505-14; PMID:22526622; http://dx.doi.org/10.1007/s00441-012-1396-6.
27. Hu Z, Huang G, Sadanandam A, Gu S, Lenburg ME, Pai M, et al. The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer. Breast Cancer Res 2010; 12:R18; PMID:20211017; http://dx.doi.org/10.1186/bcr2487.
28. Jones L, Wei G, Sevcikova S, Phan V, Jain S, Shieh A, et al. Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia. J Exp Med 2010; 207:2581-94; PMID:21059853; http://dx.doi.org/10.1084/jem.20091071.
29. Wei G, Ku S, Ma GK, Saito S, Tang AA, Zhang J, et al. HIPK2 represses beta-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis. Proc Natl Acad Sci U S A 2007; 104:13040-5; PMID:17666529; http://dx.doi.org/10.1073/pnas.0703213104.